Eastern Europe’s newest cluster
Olomouc – A new cluster with a focus on drug development and diagnostics has been established near Palacky University in Olmouc. Called MedChemBio, the centre seeks to attract companies with an interest in medicinal and biological chemistry, and offers support in the development and production of active ingredients. It is supported by CzechInvest and the EU CORMET programme.
Soon, a clinical trial unit will be established there for testing the safety and efficacy of newly developed compounds. Research at the centre will focus on anti-cancer drugs and anti-infectives, as well as on bringing together all the companies and institutions working in the field, said Marian Hayduch, one of the cluster’s founders.
Several companies have already relocated to MedBioChem, among them CRO Qunita-Analytica s.r.o., Life Sciences Capial s.r.o., reagents supplier OlChemIm Ltd., MD - Pharm, s.r.o., SciTech spol. s r.o., BioPatterns s.r.o., EUROTEX, spol. s.r.o., and STAR Czech s.r.o.